Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Absorption of Nutrients01:19

Absorption of Nutrients

Absorption refers to taking dietary nutrients from the intestinal lumen for transportation throughout the body. After digestion in the small intestine, carbohydrates, proteins, and fats are broken down into simpler forms. These essential macronutrients and other vital substances, such as vitamins, minerals, and water, are then prepared for absorption into the bloodstream.
Enterocytes, which are specialized polar epithelial cells, line the mucosa of the small intestinal walls. These cells...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Prognostic Role of Serum Procalcitonin for Adult Patients with Acute Diarrhea in the Emergency Department.

Diagnostics (Basel, Switzerland)·2025
Same author

Heart Failure in Older Patients: An Update.

Journal of clinical medicine·2025
Same author

Intestinal Inflammation and Permeability in Patients Recovered from SARS-CoV-2 Infection.

Digestive diseases (Basel, Switzerland)·2024
Same author

Acute Diarrhea in a Tertiary Emergency Department: From Readmission Determinants to Antibiotic Prescription.

Antibiotics (Basel, Switzerland)·2024
Same author

Mild cognitive impairment and microbiota: what is known and future perspectives.

Frontiers in medicine·2024
Same author

Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Jul 5, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Classification of malabsorption syndromes.

Massimo Montalto1, Luca Santoro, Ferruccio D'Onofrio

  • 1Institute of Internal Medicine, Catholic University, Rome, Italy. mmontalto@rm.unicatt.it

Digestive Diseases (Basel, Switzerland)
|April 24, 2008
PubMed
Summary
This summary is machine-generated.

This study introduces a new classification for malabsorption syndrome based on underlying causes like digestive issues or reduced intestinal surface. This framework aids in understanding and diagnosing various malabsorption conditions.

Related Experiment Videos

Last Updated: Jul 5, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pathophysiology

Background:

  • Malabsorption syndrome presents with complex symptoms due to maldigestion or malabsorption.
  • Existing classifications are inadequate due to the intricate nature of nutrient absorption and multifactorial diseases.
  • A clear classification is needed for better understanding and management of malabsorption.

Purpose of the Study:

  • To propose a novel classification system for diseases causing malabsorption syndrome.
  • To categorize these diseases based on their primary etiopathogenetic mechanisms.
  • To provide insights into the specific mechanisms underlying each disease category.

Main Methods:

  • Literature review of conditions causing malabsorption.
  • Development of a new classification based on etiopathogenetic mechanisms.
  • Categorization into: (a) altered digestive processes, (b) altered uptake/transport due to surface damage, and (c) miscellaneous.

Main Results:

  • A proposed classification system is presented.
  • Diseases are grouped according to their role in malabsorption.
  • Mechanisms for each disease are discussed.

Conclusions:

  • The proposed classification offers a structured approach to understanding malabsorption.
  • Categorizing by mechanism aids in diagnosis and research.
  • Further refinement of classification may improve patient outcomes.